Share Email Print

Proceedings Paper

Identifying incremental costs for successive generations of implantable cardiac pacemakers
Author(s): Allen A. Hughes
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

This paper provides an assessment of the incremental expected costs of increasingly sophisticated generations of cardiac pacemaker technology. A decision analytic framework is used to calculate expected costs of pacemaker therapy over a five-year period, taking into account failure rate estimates for the various generations, device replacement costs, hospital fees, physician's fees, follow-up care, and patient lost time in follow-up care. For five years of pacing therapy, the incremental cost difference between nonprogrammable and multiprogrammable is $1887; between multiprogrammable and dual-chamber is $3321; and between dual-chamber and dual-chamber rate-responsive is $676. Incremental benefits were found extremely difficult to quantify, monetarize, or translate to a scale for comparison with costs. However, medical literature indicates a decreasing level of risk for mortality and morbidity, owing to increased hemodynamic benefits from the more recent generations of high technology pacemakers.

Paper Details

Date Published: 6 December 1994
PDF: 14 pages
Proc. SPIE 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care, (6 December 1994); doi: 10.1117/12.195486
Show Author Affiliations
Allen A. Hughes, George Mason Univ. (United States)

Published in SPIE Proceedings Vol. 2307:
Health Care Technology Policy I: The Role of Technology in the Cost of Health Care
Warren S. Grundfest, Editor(s)

© SPIE. Terms of Use
Back to Top